The Saudi Commission for Health Specialties participated as part of the Saudi Pavilion delegation in the BIO International Convention for Biotechnology 2025, held in Boston, United States, from June 16 to 19. The convention is regarded as one of the world’s leading global platforms in the fields of biotechnology and health innovation.
During its participation, SCFHS highlighted its role as a leading national regulatory authority dedicated to developing healthcare competencies and enabling them to compete globally. This is achieved through an integrated education and training ecosystem focused on the quality of outcomes. The Commission also took part in a workshop titled “Empowering a Biotechnology-Ready Health Workforce: The Role of the Saudi Commission for Health Specialties in Capacity Building.” The workshop addressed several key themes, including the transformation of the healthcare workforce ecosystem, emerging skills in the biotechnology sector, and challenges related to workforce readiness and talent attraction. This participation reflects SCFHS’s commitment to building a sustainable healthcare ecosystem that supports innovation and keeps pace with the growth of the biotechnology sector.
The Commission concluded its participation by signing a cooperation agreement with Sanofi, aimed at developing joint training programs and enhancing the exchange of expertise in the fields of biomanufacturing, health innovation, and clinical trials. The agreement also includes collaboration in capacity building, knowledge transfer, and the development of professional frameworks, contributing to localization efforts and the development of national capabilities in biotechnology and digital health, in line with the objectives of Saudi Vision 2030.